Global Meperidine (Demerol) Market Insights and Forecast to 2026

Publisher Name :
Date: 02-Jul-2020
No. of pages: 111
Inquire Before Buying

Meperidine(Demerol) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Meperidine(Demerol) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Meperidine(Demerol) market is segmented into

- Powder

- Liquid

Segment by Application, the Meperidine(Demerol) market is segmented into

- Anesthesia

- Cough Suppressant

- Diarrhea suppressant

Regional and Country-level Analysis

The Meperidine(Demerol) market is analysed and market size information is provided by regions (countries).

The key regions covered in the Meperidine(Demerol) market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Meperidine(Demerol) Market Share Analysis

Meperidine(Demerol) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Meperidine(Demerol) business, the date to enter into the Meperidine(Demerol) market, Meperidine(Demerol) product introduction, recent developments, etc.

The major vendors covered:

- Pfizer Inc

- Purdue Pharma

- Boehringer Ingelheim

- Janssen Pharmaceuticals

- Actavis Plc

- Sanofi

- Sun Pharmaceutical Industries Ltd

- Mallinckrodt Pharmaceuticals

- Endo Pharmaceuticals Inc

- Egalet

Global Meperidine (Demerol) Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Meperidine(Demerol) Product Introduction
1.2 Market Segments
1.3 Key Meperidine(Demerol) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Meperidine(Demerol) Market Size Growth Rate by Type
1.4.2 Powder
1.4.3 Liquid
1.5 Market by Application
1.5.1 Global Meperidine(Demerol) Market Size Growth Rate by Application
1.5.2 Anesthesia
1.5.3 Cough Suppressant
1.5.4 Diarrhea suppressant
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meperidine(Demerol) Market Size, Estimates and Forecasts
2.1.1 Global Meperidine(Demerol) Revenue 2015-2026
2.1.2 Global Meperidine(Demerol) Sales 2015-2026
2.2 Global Meperidine(Demerol), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Meperidine(Demerol) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Meperidine(Demerol) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Meperidine(Demerol) Competitor Landscape by Players
3.1 Meperidine(Demerol) Sales by Manufacturers
3.1.1 Meperidine(Demerol) Sales by Manufacturers (2015-2020)
3.1.2 Meperidine(Demerol) Sales Market Share by Manufacturers (2015-2020)
3.2 Meperidine(Demerol) Revenue by Manufacturers
3.2.1 Meperidine(Demerol) Revenue by Manufacturers (2015-2020)
3.2.2 Meperidine(Demerol) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Meperidine(Demerol) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Meperidine(Demerol) Revenue in 2019
3.2.5 Global Meperidine(Demerol) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Meperidine(Demerol) Price by Manufacturers
3.4 Meperidine(Demerol) Manufacturing Base Distribution, Product Types
3.4.1 Meperidine(Demerol) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meperidine(Demerol) Product Type
3.4.3 Date of International Manufacturers Enter into Meperidine(Demerol) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Meperidine(Demerol) Market Size by Type (2015-2020)
4.1.1 Global Meperidine(Demerol) Sales by Type (2015-2020)
4.1.2 Global Meperidine(Demerol) Revenue by Type (2015-2020)
4.1.3 Meperidine(Demerol) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Meperidine(Demerol) Market Size Forecast by Type (2021-2026)
4.2.1 Global Meperidine(Demerol) Sales Forecast by Type (2021-2026)
4.2.2 Global Meperidine(Demerol) Revenue Forecast by Type (2021-2026)
4.2.3 Meperidine(Demerol) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Meperidine(Demerol) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Meperidine(Demerol) Market Size by Application (2015-2020)
5.1.1 Global Meperidine(Demerol) Sales by Application (2015-2020)
5.1.2 Global Meperidine(Demerol) Revenue by Application (2015-2020)
5.1.3 Meperidine(Demerol) Price by Application (2015-2020)
5.2 Meperidine(Demerol) Market Size Forecast by Application (2021-2026)
5.2.1 Global Meperidine(Demerol) Sales Forecast by Application (2021-2026)
5.2.2 Global Meperidine(Demerol) Revenue Forecast by Application (2021-2026)
5.2.3 Global Meperidine(Demerol) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Meperidine(Demerol) by Country
6.1.1 North America Meperidine(Demerol) Sales by Country
6.1.2 North America Meperidine(Demerol) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Meperidine(Demerol) Market Facts & Figures by Type
6.3 North America Meperidine(Demerol) Market Facts & Figures by Application
7 Europe
7.1 Europe Meperidine(Demerol) by Country
7.1.1 Europe Meperidine(Demerol) Sales by Country
7.1.2 Europe Meperidine(Demerol) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meperidine(Demerol) Market Facts & Figures by Type
7.3 Europe Meperidine(Demerol) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Meperidine(Demerol) by Region
8.1.1 Asia Pacific Meperidine(Demerol) Sales by Region
8.1.2 Asia Pacific Meperidine(Demerol) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Meperidine(Demerol) Market Facts & Figures by Type
8.3 Asia Pacific Meperidine(Demerol) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Meperidine(Demerol) by Country
9.1.1 Latin America Meperidine(Demerol) Sales by Country
9.1.2 Latin America Meperidine(Demerol) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Meperidine(Demerol) Market Facts & Figures by Type
9.3 Central & South America Meperidine(Demerol) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Meperidine(Demerol) by Country
10.1.1 Middle East and Africa Meperidine(Demerol) Sales by Country
10.1.2 Middle East and Africa Meperidine(Demerol) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Meperidine(Demerol) Market Facts & Figures by Type
10.3 Middle East and Africa Meperidine(Demerol) Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Meperidine(Demerol) Products Offered
11.1.5 Pfizer Inc Related Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Corporation Information
11.2.2 Purdue Pharma Description and Business Overview
11.2.3 Purdue Pharma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Purdue Pharma Meperidine(Demerol) Products Offered
11.2.5 Purdue Pharma Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Meperidine(Demerol) Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Janssen Pharmaceuticals
11.4.1 Janssen Pharmaceuticals Corporation Information
11.4.2 Janssen Pharmaceuticals Description and Business Overview
11.4.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Janssen Pharmaceuticals Meperidine(Demerol) Products Offered
11.4.5 Janssen Pharmaceuticals Related Developments
11.5 Actavis Plc
11.5.1 Actavis Plc Corporation Information
11.5.2 Actavis Plc Description and Business Overview
11.5.3 Actavis Plc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Actavis Plc Meperidine(Demerol) Products Offered
11.5.5 Actavis Plc Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Meperidine(Demerol) Products Offered
11.6.5 Sanofi Related Developments
11.7 Sun Pharmaceutical Industries Ltd
11.7.1 Sun Pharmaceutical Industries Ltd Corporation Information
11.7.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
11.7.3 Sun Pharmaceutical Industries Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceutical Industries Ltd Meperidine(Demerol) Products Offered
11.7.5 Sun Pharmaceutical Industries Ltd Related Developments
11.8 Mallinckrodt Pharmaceuticals
11.8.1 Mallinckrodt Pharmaceuticals Corporation Information
11.8.2 Mallinckrodt Pharmaceuticals Description and Business Overview
11.8.3 Mallinckrodt Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mallinckrodt Pharmaceuticals Meperidine(Demerol) Products Offered
11.8.5 Mallinckrodt Pharmaceuticals Related Developments
11.9 Endo Pharmaceuticals Inc
11.9.1 Endo Pharmaceuticals Inc Corporation Information
11.9.2 Endo Pharmaceuticals Inc Description and Business Overview
11.9.3 Endo Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Endo Pharmaceuticals Inc Meperidine(Demerol) Products Offered
11.9.5 Endo Pharmaceuticals Inc Related Developments
11.10 Egalet
11.10.1 Egalet Corporation Information
11.10.2 Egalet Description and Business Overview
11.10.3 Egalet Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Egalet Meperidine(Demerol) Products Offered
11.10.5 Egalet Related Developments
11.1 Pfizer Inc
11.1.1 Pfizer Inc Corporation Information
11.1.2 Pfizer Inc Description and Business Overview
11.1.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc Meperidine(Demerol) Products Offered
11.1.5 Pfizer Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Meperidine(Demerol) Market Estimates and Projections by Region
12.1.1 Global Meperidine(Demerol) Sales Forecast by Regions 2021-2026
12.1.2 Global Meperidine(Demerol) Revenue Forecast by Regions 2021-2026
12.2 North America Meperidine(Demerol) Market Size Forecast (2021-2026)
12.2.1 North America: Meperidine(Demerol) Sales Forecast (2021-2026)
12.2.2 North America: Meperidine(Demerol) Revenue Forecast (2021-2026)
12.2.3 North America: Meperidine(Demerol) Market Size Forecast by Country (2021-2026)
12.3 Europe Meperidine(Demerol) Market Size Forecast (2021-2026)
12.3.1 Europe: Meperidine(Demerol) Sales Forecast (2021-2026)
12.3.2 Europe: Meperidine(Demerol) Revenue Forecast (2021-2026)
12.3.3 Europe: Meperidine(Demerol) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Meperidine(Demerol) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Meperidine(Demerol) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Meperidine(Demerol) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Meperidine(Demerol) Market Size Forecast by Region (2021-2026)
12.5 Latin America Meperidine(Demerol) Market Size Forecast (2021-2026)
12.5.1 Latin America: Meperidine(Demerol) Sales Forecast (2021-2026)
12.5.2 Latin America: Meperidine(Demerol) Revenue Forecast (2021-2026)
12.5.3 Latin America: Meperidine(Demerol) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Meperidine(Demerol) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Meperidine(Demerol) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Meperidine(Demerol) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Meperidine(Demerol) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Meperidine(Demerol) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Meperidine(Demerol) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Meperidine(Demerol) Market Segments
Table 2. Ranking of Global Top Meperidine(Demerol) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Meperidine(Demerol) Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Powder
Table 5. Major Manufacturers of Liquid
Table 6. Global Meperidine(Demerol) Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Meperidine(Demerol) Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Meperidine(Demerol) Sales by Regions 2015-2020 (K Units)
Table 9. Global Meperidine(Demerol) Sales Market Share by Regions (2015-2020)
Table 10. Global Meperidine(Demerol) Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Meperidine(Demerol) Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Meperidine(Demerol) Sales Share by Manufacturers (2015-2020)
Table 13. Global Meperidine(Demerol) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Meperidine(Demerol) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meperidine(Demerol) as of 2019)
Table 15. Meperidine(Demerol) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Meperidine(Demerol) Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Meperidine(Demerol) Price (2015-2020) (USD/Unit)
Table 18. Meperidine(Demerol) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Meperidine(Demerol) Product Type
Table 20. Date of International Manufacturers Enter into Meperidine(Demerol) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 23. Global Meperidine(Demerol) Sales Share by Type (2015-2020)
Table 24. Global Meperidine(Demerol) Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Meperidine(Demerol) Revenue Share by Type (2015-2020)
Table 26. Meperidine(Demerol) Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 28. Global Meperidine(Demerol) Sales Share by Application (2015-2020)
Table 29. North America Meperidine(Demerol) Sales by Country (2015-2020) (K Units)
Table 30. North America Meperidine(Demerol) Sales Market Share by Country (2015-2020)
Table 31. North America Meperidine(Demerol) Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Meperidine(Demerol) Revenue Market Share by Country (2015-2020)
Table 33. North America Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 34. North America Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Table 35. North America Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 36. North America Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Table 37. Europe Meperidine(Demerol) Sales by Country (2015-2020) (K Units)
Table 38. Europe Meperidine(Demerol) Sales Market Share by Country (2015-2020)
Table 39. Europe Meperidine(Demerol) Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Meperidine(Demerol) Revenue Market Share by Country (2015-2020)
Table 41. Europe Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 42. Europe Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Table 43. Europe Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 44. Europe Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Meperidine(Demerol) Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Meperidine(Demerol) Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Meperidine(Demerol) Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Meperidine(Demerol) Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Table 53. Latin America Meperidine(Demerol) Sales by Country (2015-2020) (K Units)
Table 54. Latin America Meperidine(Demerol) Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Meperidine(Demerol) Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Meperidine(Demerol) Revenue Market Share by Country (2015-2020)
Table 57. Latin America Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 58. Latin America Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Table 59. Latin America Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 60. Latin America Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Meperidine(Demerol) Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Meperidine(Demerol) Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Meperidine(Demerol) Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Meperidine(Demerol) Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Meperidine(Demerol) Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Meperidine(Demerol) Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Table 69. Pfizer Inc Corporation Information
Table 70. Pfizer Inc Description and Major Businesses
Table 71. Pfizer Inc Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Pfizer Inc Product
Table 73. Pfizer Inc Recent Development
Table 74. Purdue Pharma Corporation Information
Table 75. Purdue Pharma Description and Major Businesses
Table 76. Purdue Pharma Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Purdue Pharma Product
Table 78. Purdue Pharma Recent Development
Table 79. Boehringer Ingelheim Corporation Information
Table 80. Boehringer Ingelheim Description and Major Businesses
Table 81. Boehringer Ingelheim Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Boehringer Ingelheim Product
Table 83. Boehringer Ingelheim Recent Development
Table 84. Janssen Pharmaceuticals Corporation Information
Table 85. Janssen Pharmaceuticals Description and Major Businesses
Table 86. Janssen Pharmaceuticals Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Janssen Pharmaceuticals Product
Table 88. Janssen Pharmaceuticals Recent Development
Table 89. Actavis Plc Corporation Information
Table 90. Actavis Plc Description and Major Businesses
Table 91. Actavis Plc Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Actavis Plc Product
Table 93. Actavis Plc Recent Development
Table 94. Sanofi Corporation Information
Table 95. Sanofi Description and Major Businesses
Table 96. Sanofi Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Sanofi Product
Table 98. Sanofi Recent Development
Table 99. Sun Pharmaceutical Industries Ltd Corporation Information
Table 100. Sun Pharmaceutical Industries Ltd Description and Major Businesses
Table 101. Sun Pharmaceutical Industries Ltd Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sun Pharmaceutical Industries Ltd Product
Table 103. Sun Pharmaceutical Industries Ltd Recent Development
Table 104. Mallinckrodt Pharmaceuticals Corporation Information
Table 105. Mallinckrodt Pharmaceuticals Description and Major Businesses
Table 106. Mallinckrodt Pharmaceuticals Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Mallinckrodt Pharmaceuticals Product
Table 108. Mallinckrodt Pharmaceuticals Recent Development
Table 109. Endo Pharmaceuticals Inc Corporation Information
Table 110. Endo Pharmaceuticals Inc Description and Major Businesses
Table 111. Endo Pharmaceuticals Inc Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Endo Pharmaceuticals Inc Product
Table 113. Endo Pharmaceuticals Inc Recent Development
Table 114. Egalet Corporation Information
Table 115. Egalet Description and Major Businesses
Table 116. Egalet Meperidine(Demerol) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Egalet Product
Table 118. Egalet Recent Development
Table 119. Global Meperidine(Demerol) Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Meperidine(Demerol) Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Meperidine(Demerol) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Meperidine(Demerol) Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Meperidine(Demerol) Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Meperidine(Demerol) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Meperidine(Demerol) Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Meperidine(Demerol) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Meperidine(Demerol) Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Meperidine(Demerol) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Meperidine(Demerol) Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Meperidine(Demerol) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Meperidine(Demerol) Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Meperidine(Demerol) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Meperidine(Demerol) Players
Table 137. Meperidine(Demerol) Customers List
Table 138. Meperidine(Demerol) Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Meperidine(Demerol) Product Picture
Figure 2. Global Meperidine(Demerol) Sales Market Share by Type in 2020 & 2026
Figure 3. Powder Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Meperidine(Demerol) Sales Market Share by Application in 2020 & 2026
Figure 6. Anesthesia
Figure 7. Cough Suppressant
Figure 8. Diarrhea suppressant
Figure 9. Meperidine(Demerol) Report Years Considered
Figure 10. Global Meperidine(Demerol) Market Size 2015-2026 (US$ Million)
Figure 11. Global Meperidine(Demerol) Sales 2015-2026 (K Units)
Figure 12. Global Meperidine(Demerol) Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Meperidine(Demerol) Sales Market Share by Region (2015-2020)
Figure 14. Global Meperidine(Demerol) Sales Market Share by Region in 2019
Figure 15. Global Meperidine(Demerol) Revenue Market Share by Region (2015-2020)
Figure 16. Global Meperidine(Demerol) Revenue Market Share by Region in 2019
Figure 17. Global Meperidine(Demerol) Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Meperidine(Demerol) Revenue in 2019
Figure 19. Meperidine(Demerol) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Meperidine(Demerol) Sales Market Share by Type (2015-2020)
Figure 21. Global Meperidine(Demerol) Sales Market Share by Type in 2019
Figure 22. Global Meperidine(Demerol) Revenue Market Share by Type (2015-2020)
Figure 23. Global Meperidine(Demerol) Revenue Market Share by Type in 2019
Figure 24. Global Meperidine(Demerol) Market Share by Price Range (2015-2020)
Figure 25. Global Meperidine(Demerol) Sales Market Share by Application (2015-2020)
Figure 26. Global Meperidine(Demerol) Sales Market Share by Application in 2019
Figure 27. Global Meperidine(Demerol) Revenue Market Share by Application (2015-2020)
Figure 28. Global Meperidine(Demerol) Revenue Market Share by Application in 2019
Figure 29. North America Meperidine(Demerol) Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Meperidine(Demerol) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Meperidine(Demerol) Sales Market Share by Country in 2019
Figure 32. North America Meperidine(Demerol) Revenue Market Share by Country in 2019
Figure 33. U.S. Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Meperidine(Demerol) Market Share by Type in 2019
Figure 38. North America Meperidine(Demerol) Market Share by Application in 2019
Figure 39. Europe Meperidine(Demerol) Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Meperidine(Demerol) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Meperidine(Demerol) Sales Market Share by Country in 2019
Figure 42. Europe Meperidine(Demerol) Revenue Market Share by Country in 2019
Figure 43. Germany Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Meperidine(Demerol) Market Share by Type in 2019
Figure 54. Europe Meperidine(Demerol) Market Share by Application in 2019
Figure 55. Asia Pacific Meperidine(Demerol) Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Meperidine(Demerol) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Meperidine(Demerol) Sales Market Share by Region in 2019
Figure 58. Asia Pacific Meperidine(Demerol) Revenue Market Share by Region in 2019
Figure 59. China Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Meperidine(Demerol) Market Share by Type in 2019
Figure 82. Asia Pacific Meperidine(Demerol) Market Share by Application in 2019
Figure 83. Latin America Meperidine(Demerol) Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Meperidine(Demerol) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Meperidine(Demerol) Sales Market Share by Country in 2019
Figure 86. Latin America Meperidine(Demerol) Revenue Market Share by Country in 2019
Figure 87. Mexico Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Meperidine(Demerol) Market Share by Type in 2019
Figure 94. Latin America Meperidine(Demerol) Market Share by Application in 2019
Figure 95. Middle East and Africa Meperidine(Demerol) Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Meperidine(Demerol) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Meperidine(Demerol) Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Meperidine(Demerol) Revenue Market Share by Country in 2019
Figure 99. Turkey Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Meperidine(Demerol) Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Meperidine(Demerol) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Meperidine(Demerol) Market Share by Type in 2019
Figure 106. Middle East and Africa Meperidine(Demerol) Market Share by Application in 2019
Figure 107. North America Meperidine(Demerol) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Meperidine(Demerol) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Meperidine(Demerol) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Meperidine(Demerol) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Meperidine(Demerol) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Meperidine(Demerol) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Meperidine(Demerol) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Meperidine(Demerol) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Meperidine(Demerol) Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Meperidine(Demerol) Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs